CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,662,139
- in 5 filings, $21.7M under 10b5-1 plans
Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-12 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −7,883 | 7,883 | ||
| 2022-02-12 | LaBrosse Nicole SVP, Chief Financial Officer | Exercise or conversion | +1,389 | 7,900 | ||
| 2022-02-12 | LaBrosse Nicole SVP, Chief Financial Officer | Shares withheld for taxes | −506 | $34.20 | $17K | 7,394 |
| 2022-02-12 | LaBrosse Nicole SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,389 | 1,389 | ||
| 2022-02-12 | Torley Helen President and CEO | Exercise or conversion | +32,795 | 584,639 | ||
| 2022-02-12 | Torley Helen President and CEO | Shares withheld for taxes | −17,266 | $34.20 | $590K | 567,373 |
| 2022-02-12 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −32,795 | 32,794 | ||
| 2022-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +8,133 | 164,979 | ||
| 2022-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Shares withheld for taxes | −2,992 | $34.94 | $105K | 161,987 |
| 2022-02-10 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Restricted Stock Units | −8,133 | 16,266 | ||
| 2022-02-10 | LaBrosse Nicole SVP, Chief Financial Officer | Exercise or conversion | +2,503 | 7,536 | ||
| 2022-02-10 | LaBrosse Nicole SVP, Chief Financial Officer | Shares withheld for taxes | −1,025 | $34.94 | $36K | 6,511 |
| 2022-02-10 | LaBrosse Nicole SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,503 | 5,005 | ||
| 2022-02-10 | Torley Helen President and CEO | Exercise or conversion | +31,282 | 568,442 | ||
| 2022-02-10 | Torley Helen President and CEO | Shares withheld for taxes | −16,598 | $34.94 | $580K | 551,844 |
| 2022-02-10 | Torley Helen President and CEO | Exercise or conversion · Restricted Stock Units | −31,282 | 62,562 | ||
| 2022-01-03 | Snyder Mark Howard SVP, General Counsel | Grant or award · Option to Purchase Common Stock | +83,142 | 83,142 | ||
| 2022-01-03 | Snyder Mark Howard SVP, General Counsel | Grant or award · Restricted Stock Unit | +30,444 | 30,444 | ||
| 2021-11-08 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
| 2021-11-08 | Torley Helen President and CEO | Sale | −37,775 | $39.62 | $1.5M | 549,385 |
Page 47 of 48 · 944 trades